Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi

differences in th sino-nasal outcome test 22 and visual analog scale symptom scores in chronic rhinosinuitis with and without nasal polyps (CROSBI ID 238632)

Prilog u časopisu | izvorni znanstveni rad | međunarodna recenzija

Gregurić, Tomislav ; Trkulja, Vladimir ; Baudoin, Tomislav ; Grgić, Marko ; Šmigovec, Igor ; Kalogjera, Livije differences in th sino-nasal outcome test 22 and visual analog scale symptom scores in chronic rhinosinuitis with and without nasal polyps // American Journal of Rhinology & Allergy, 30 (2016), 2; 107-112. doi: 10.2500/ajra.2016.30.4274

Podaci o odgovornosti

Gregurić, Tomislav ; Trkulja, Vladimir ; Baudoin, Tomislav ; Grgić, Marko ; Šmigovec, Igor ; Kalogjera, Livije

engleski

differences in th sino-nasal outcome test 22 and visual analog scale symptom scores in chronic rhinosinuitis with and without nasal polyps

Chronic rhinosinusitis (CRS) with and without polyps has a high impact on health-related quality of life (HRQL), but the difference in HRQL and symptom presentation between two clinical phenotypes of CRS has not been specifically evaluated before now. Objective was to evaluate patterns of symptoms and HRQL disease-specific domains affected in patients with CRS by comparing differences between two clinical phenotypes, adjusted for demographics, major risk factors, comorbidities, current medical treatment, and previous surgery. A group of 251 patients with CRS completed the visual analog scale (VAS) symptom severity score and the Sino-Nasal Outcome Test 22 (SNOT- 22) questionnaire. Data sets were analyzed by using principal component analysis (PCA) to identify a set of symptom components, together with the items excluded from PCA, which were then analyzed for differences between patients with CRS with nasal polyps (CRSwNP) and patients with CRS without nasal polyps (CRSsNP). PCA of SNOT-22 items identified six components, three referred to CRS-specific symptoms termed "nasal" ; "extranasal, rhinologic" ; and "olfactory/cough" ; and three referred to HRQL impairment termed "sleep disturbance, " "functional disturbance, " and "emotional disturbance." Nasal obstruction, ear pain, ear fullness, and fatigue were excluded from PCA and treated as separate outcomes. Patients with CRSwNP had significantly worse nasal symptoms, olfactory/cough symptoms, and nasal obstruction. Patients with CRSsNP scored significantly worse with regard to fatigue and to sleep and functional disturbances. The PCA results for VAS scores identified three symptom components: pain, nasal symptoms, and pharyngeal symptoms. Patients with CRSwNP had significantly worse VAS nasal symptoms but less pronounced VAS pain symptoms than patients with CRSsNP. The total SNOT-22 score between the groups was not significantly different. With controlling of covariates that may influence the severity of the disease, this study showed significant differences in symptom patterns and different aspects of HRQL impairment between patients with CRSwNP and patients with CRSsNP, however, with no difference in the total HRQL score.

chronic rhinosinuitis, nasal polyps, SNOT-22

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o izdanju

30 (2)

2016.

107-112

objavljeno

1945-8924

10.2500/ajra.2016.30.4274

Povezanost rada

Kliničke medicinske znanosti

Poveznice
Indeksiranost